Chen, P.-H., Chang, W.-C., Jhou, H.-J., Chen, H.-Y., Kao, L.-T., Hsieh, T. Y.-J., Dai, M.-S., Lee, C.-H.

COVID-19 mRNA vaccination and immune-related adverse events in patients with cancer receiving immune checkpoint inhibitors: a target trial emulation study

25 de June de 2026 by Chen, P.-H., Chang, W.-C., Jhou, H.-J., Chen, H.-Y., Kao, L.-T., Hsieh, T. Y.-J., Dai, M.-S., Lee, C.-H.

Background
COVID-19 messenger RNA (mRNA) vaccines enhance immune checkpoint inhibitor (ICI) efficacy through type I interferon responses, but may theoretically increase the burden of immune-related adverse events (irAEs). This study aimed to determine…